E Orexigen Keeps Getting Slammed On Negative News
Shares of Orexigen Therapeutics (OREX) fell 13% in today’s trading session after the company reported that its health-benefit study had to end early. This study was known as the Light study, which enrolled approximately 9,000 patients to prove that taking Contrave did not increase cardiovascular risks for patients. Results from the trial were released early […]
What Dr. Strangelove Can Teach Us About Market Corrections
The full title of the classic 1964 movie is “Dr. Strangelove, Or: How I Learned to Stop Worrying and Love the Bomb”. Income focused stock market investors need to follow the advice of Dr. Strangelove and get ready to “love the correction” that many news hosts and experts are forecasting for the stock market. Financial […]
EC The Best Approach To Adjustable Retirement Withdrawals
A great deal of recent research has focused on strategies that adjust withdrawals in retirement depending on investment experience. But such strategies disrupt retirement plans by causing withdrawals to vary a lot from year to year. I’ll examine the prominent approaches for determining what will work best for clients. A simple example of an adjustable […]
Gold Daily And Silver Weekly Charts – Coiling Like A Snake – Whip It Good
When a problem comes along You must whip it When something’s goin’ wrong You must whip it Devo – Whip It The metals continue coiling as gold is held around the 1200 level and silver between 16 and 17. The ‘delivery action’ is in silver this month, and the relative scarcity of deliverable warehouse metal at […]
E FDA Panel Backs Orkambi For Cystic Fibrosis Patients
Shares of Vertex Pharmaceuticals (VRTX) are up 7% after a panel of Federal Health advisers agreed that Orkambi should be approved for Cystic Fibrosis patients. The panel voted 12-1 for approval even though the panel had some doubts about whether or not Orkambi showed a huge statistical improvement in lung function or not. This new […]
My Secrets To 297%+ Gains In Biotech Investing
I am out in Las Vegas all week at the MoneyShow investing conference. I am giving a two-hour presentation here on the basics of properly managing a portfolio in the volatile biotech space. The presentation contains a lot of the lessons I have gleaned from over two decades of successfully investing in the biotech sector. […]
Macy’s, J.C. Penney Wrap Up Earnings Season
Macy’s, J. C. Penney put a bow on earnings season. Christine Short from Estimize talks on Yahoo Finance. Video Length: 00:03:51
Oil Jumps Above $61 After API Shows Larger-Than-Expected Inventory Draw
Following last week’s biggest inventory draw since September 2014 of 3.88 million barrels, expectations were for a relatively small 250k draw this week (with builds in gasoline and distillates). API reported a considerably bigger than expected 2 million bbl draw (with a 827k draw from Cushing). WTI Crude has pushed up above $61 on the news. A 2nd […]
Projected Revenue Growth Makes Plug Power Bullish: An Algorithmic Analysis
Plug Power Inc.(PLUG) released its most recent earnings report Monday morning, showing the company continues to be unprofitable. In fact, losses increased to $11.1 million, more than what they were a year ago, due to increasing costs. This is especially true for total administrative costs, which doubled during the first quarter which ended March 31st compared […]
